Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods

Modern Pathology

Volumn 16, Issue 9, 2003, Pages 951-957

  Hsu, Chih Yi ^a   Ho, Donald Ming Tak ^b   Yang, Ching Fen ^b   Chiang, Hung ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Astrocytoma; Immunohistochemistry; Interobserver reproducibility; MIB 1

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADOLESCENT; ADULT; AGED; ANALYTIC METHOD; AREA FRACTION ESTIMATE; ARTICLE; ASTROCYTOMA; CELL COUNT; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUNTING METHOD; DIFFERENTIAL DIAGNOSIS; FEMALE; GLIOBLASTOMA; GRATICULE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INTERMETHOD COMPARISON; INTEROBSERVER REPRODUCIBILITY; LABELING INDEX; LINE INTERSECTION ESTIMATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; STAINING; STANDARD; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0141853362     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000084631.64279.BC     Document Type: Article

References (27)

1. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 1986;10:611-7.
2. Montine TJ, Vandersteenhoven JJ, Aguzzi A, Boyko OB, Dodge RK, Kerns BJ, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery 1994;34:674-8.
3. Lindboe CF, Torp SH. Comparison of Ki-67 equivalent antibodies. J Clin Pathol 2002;55:467-71.
4. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology 1993;22:355-60.
5. Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases. Cancer 1998;82:2459-66.
6. Tihan T, Davis R, Elowitz E, DiCostanzo D, Moll U. Practical value of Ki-67 and p53 labeling indexes in stereotactic biopsies of diffuse and pilocytic astrocytomas. Arch Pathol Lab Med 2000;124:108-13.
7. Schiffer D, Cavalla P, Chio A, Richiardi P, Giordana MT. Proliferative activity and prognosis of low-grade astrocytomas. J Neurooncol 1997;34:31-5.
8. Enestrom S, Vavruch L, Franlund B, Nordenskjold B. Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas. Neurochirurgie 1998;44:25-30.
9. Pollack IF, Campbell JW, Hamilton RL, Martinez AJ, Bozik ME. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer 1997;79:849-56.
10. McKeever PE, Ross DA, Strawderman MS, Brunberg JA, Greenberg HS, Junck L. A comparison of the predictive power for survival in gliomas provided by MIB-1, bromodeoxyuridine and proliferating cell nuclear antigen with histopathologic and clinical parameters. J Neuropathol Exp Neurol 1997;56:798-805.
11. Marie D, Liu Y, Moore SA, Brown HG, Silverman JF, D'Amico F, et al. Interobserver variability associated with the MIB-1 labeling index: high levels suggest limited prognostic usefulness for patients with primary brain tumors. Cancer 2001;92:2720-6.
12. Bland M, editor. An introduction to medical statistics. 3rd ed. Oxford, U.K.: Oxford University Press; 2000. p. 270-2.
13. Rosner B, editor. Fundamentals of biostatistics. 4th ed. Belmont, CA: Duxbury Press; 1995. p. 518-21.
14. Rosner B, editor. Fundamentals of biostatistics. 4th ed. Belmont, CA: Duxbury Press; 1995. p. 327.
15. Bland JM, Altman DG. Measurement error proportional to the mean. BMJ 1996;313:106.
16. Fleiss JG, editor. Statistical methods for rates and proportions. New York: Wiley; 1981. p. 225-32.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
18. Scott JN, Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, et al. Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 1998;25:197-201.
19. Kirkegaard LJ, DeRose PB, Yao B, Cohen C. Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas. Prognostic significance. Am J Clin Pathol 1998;109:69-74.
20. Sallinen PK, Haapasalo HK, Visakorpi T, Helen PT, Rantala IS, Isola JJ, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J Pathol 1994;174:275-82.
21. Amin MR, Kurosaki M, Watanabe T, Tanaka S, Hori T. A comparative study of MIB-1 staining indices of gliomas measured by NIH Image analysis program and conventional manual cell counting method. Neurol Res 2000;22:495-500.
22. Ide M, Jimbo M, Yamamoto M, Kubo O. Tumor cell counting using an image analysis program for MIB-1 immunohistochemistry. Neurol Med Chir (Tokyo) 1997;37:158-62.
23. Ren Y, Munyer P, Kepes JJ, Cansler M, Collins J, Gayed B, et al. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system. Appl Immunohistochem Mol Morphol 2001;9:14-8.
24. Seidal T, Balaton AJ, Battifora H. Interpretation and quantification of immunostains. Am J Surg Pathol 2001;25:1204-7.
25. Bigio EH, Colvin SM, Mickey BE, White CL III, Rushing EJ. Radiation change versus recurrent astrocytoma: diagnostic utility of the proliferation index? J Neurooncol 1999;41:55-63.
26. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2-11.
27. Grzybicki DM, Moore SA. Implications of prognostic markers in brain tumors. Clin Lab Med 1999;19:833-47.